Target Price | $50.33 |
Price | $27.24 |
Potential |
84.78%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Magenta Therapeutics Inc 2025 .
The average Magenta Therapeutics Inc target price is $50.33.
This is
84.78%
register free of charge
$84.00
208.37%
register free of charge
$36.00
32.16%
register free of charge
|
|
A rating was issued by 10 analysts: 10 Analysts recommend Magenta Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Magenta Therapeutics Inc stock has an average upside potential 2025 of
84.78%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 2.83 | 3.48 |
22.95% | ||
Net Margin | -8,763.52% | -1,950.69% |
77.74% |
8 Analysts have issued a sales forecast Magenta Therapeutics Inc 2024 . The average Magenta Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
4 Magenta Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Magenta Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -8.45 | -2.31 |
59.00% | 72.66% | |
P/E | negative | |
EV/Sales | 126.26 |
4 Analysts have issued a Magenta Therapeutics Inc forecast for earnings per share. The average Magenta Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Magenta Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Magenta Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.